Skip to content

17th May 2024

MedTech World London: Lindus Health Co-Founder joins elite speaker lineup

MedTech World is thrilled to announce that Meri Beckwith, Co-Founder of Lindus Health, will be joining us as both a speaker and pitch competitor at the upcoming MedTech World Roadshow in London on May 29th. 

Lindus Health has been shaking things up with their groundbreaking “All-in-One Diagnostics CRO”, a cutting-edge contract research organisation (CRO) tailored for sponsors eager to launch diagnostic products.

Meri Beckwith: Innovating from personal experience

Get ready to be inspired by Meri Beckwith, one of the visionary co-founders of Lindus Health, taking the stage at our upcoming event. With a background working closely with healthtech and biotech startups, Beckwith’s journey was fueled by frustration with the slow pace of clinical research. After experiencing a clinical trial firsthand, he was driven to revolutionise the process for both sponsors and patients. Lindus Health emerged as a next-generation CRO, pioneering faster and more reliable clinical trials.

As a Co-Founder and Board Member at Lindus Health, Beckwith brings a wealth of experience from his time as a Venture Partner at OMERS Ventures and an Investment Manager at Oxford Capital Partners. His passion for supporting biotech and digital health companies shines through his role as an angel investor. Not content with just being an investor, Beckwith actively participated in COVID-19 vaccine trials as a volunteer, gaining valuable insights into how patient-focused approaches can enhance trial outcomes.

Beckwith holds a BS in Biological Sciences from the University of Oxford, along with degrees from Ampleforth College and Aiglon College. With Beckwith at the forefront, Lindus Health is redefining the future of clinical research, and his insights are sure to leave a lasting impact on our audience.

Transforming clinical trials

Lindus Health continues to make waves in the clinical trial arena, solidifying their position as industry leaders. 

Their recent study, published in MedRxiv, sheds light on the factors influencing clinical trial participation among ethnic minorities. Partnering with the University of Oxford, Lindus conducted a qualitative study, gathering insights from both research professionals and the general population through meticulously crafted eSurveys.

In April, Lindus unveiled their groundbreaking “All-in-One Diagnostics CRO,” tailored for sponsors venturing into diagnostic product markets. This innovative offering integrates expert CRO services with Lindus’ vast experience in diagnostic clinical trials, augmented by their repository of over 30 million electronic health records (EHRs) and their proprietary eClinical platform, Citrus™. This all-inclusive solution streamlines research processes and addresses recruitment and data management challenges for large-scale studies.

Adding to their impressive lineup, Lindus welcomed Dr. Tim Garnett, former Chief Medical Officer at Eli Lilly, to their advisory board. Garnett joins esteemed advisor Dr. Robert Langer, co-founder of Moderna, Inc., and Institute Professor at MIT. Lindus Health’s commitment to excellence and innovation is evident in their continued efforts to advance clinical research and improve healthcare outcomes.

About Lindus Health

Lindus Health stands out as the “anti-CRO,” revolutionising clinical trials for life science pioneers. Their unique approach ensures faster, more reliable trials by aligning incentives and integrating a top-notch clinical operations team with our cutting-edge software platform. With access to 30 million Electronic Health Records, they handle every aspect of clinical study execution.

To date, Lindus Health has enrolled over 30,000 patients in diagnostic trials across the US, UK, and Europe. Their track record speaks for itself, with successful trials spanning various therapeutic areas including oncology, infectious disease, respiratory, and women’s health.

MedTech World returns to London with a bang!

After the resounding success of last year’s event, we’re excited to welcome our delegates, old and new, to the comeback of the MedTech World London Roadshow, this time in collaboration with Queen Mary University of London. Mark your calendars for May 29, 2024, for a day filled with innovation and inspiration.

Our venue of choice is the prestigious Perrin Lecture Theatre, housed within the renowned Blizard Building on campus. With state-of-the-art facilities and a capacity of up to 400 attendees, this award-winning venue sets the stage for impactful lectures and conferences. Plus, it seamlessly connects with the Garrod building, providing convenient breakout rooms for interactive sessions.

Join us at:

Perrin Lecture Theatre, Blizard Building, Whitechapel campus, 4 Newark St, London E1 2AT, United Kingdom.

Get ready to immerse yourself in the latest advancements in MedTech and network with industry leaders and innovators.

Don’t forget to get your tickets, and see you there!